EUVIMEDEUVIMED entdecken
Crossref

Advances in Chronic Wound Management: The Role of Antibiofilm-Based Wound Dressings and Theranostic Innovations

Jaspreet Kaur, Malkiet Kaur, Geeta Aggarwal, Gitika Arora Dhingra, Manju Nagpal

International Journal of Drug Delivery Technology · 24.04.2026 · 16 (19s)

DOI: 10.25258/ijddt.16.19s.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 24.04.2026. Verfasst von Jaspreet Kaur und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic wounds constitute a significant public health burden, with Medicare spending over $30 billion annually on them. For doctors, these wounds provide a problem since they frequently show resistance to conventional therapy. Recent findings about the role of biofilms in the pathogenesis of chronic wounds have led to the consideration of biofilm eradication as a possible therapeutic strategy. Biofilms, which are incredibly resilient and impervious to host defences and antibiotic treatments, are composed of closely packed bacterial clusters coated with extracellular polymeric substances (EPS). Biofilms are believed to be the source of more than 65% of persistent bacterial infections, making wound healing more challenging. Despite the potential of traditional antibiofilm treatments such as silver, iodine, and antimicrobial peptides, problems including low patient compliance, bacterial resistance, and exorbitant prices prevent their widespread use. Nanotechnology breakthroughs have led to dressings based on nanoparticles that are highly effective against biofilms, offering controlled release, targeted medicine administration, and reduced adverse effects. Furthermore, theranostic dressings, which combine therapeutic and diagnostic properties, are becoming a groundbreaking method of wound care that enables accurate drug administration and real-time monitoring. Despite their promise, there are still obstacles to overcome to improve medicinal applications, environmental sustainability, and cost-effectiveness. Future initiatives should focus on developing environmentally friendly materials, expanding access through insurance, and using combination treatments to enhance treatment regimens for chronic wounds. Technologies such as theranostics and nanoparticles can transform the treatment of chronic wounds by offering less invasive, more efficient options.

Zitieren

APA

Kaur, J., Kaur, M., Aggarwal, G., Dhingra, G. A., & Nagpal, M. (2026). Advances in Chronic Wound Management: The Role of Antibiofilm-Based Wound Dressings and Theranostic Innovations. International Journal of Drug Delivery Technology, 16(19s). https://doi.org/10.25258/ijddt.16.19s.7

Vancouver

Kaur J, Kaur M, Aggarwal G, Dhingra GA, Nagpal M. Advances in Chronic Wound Management: The Role of Antibiofilm-Based Wound Dressings and Theranostic Innovations. International Journal of Drug Delivery Technology. 2026;16(19s). doi:10.25258/ijddt.16.19s.7

BibTeX
@article{Kaur2026,
  author = {Kaur, Jaspreet and Kaur, Malkiet and Aggarwal, Geeta and Dhingra, Gitika Arora and Nagpal, Manju},
  title = {Advances in Chronic Wound Management: The Role of Antibiofilm-Based Wound Dressings and Theranostic Innovations},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {19s},
  doi = {10.25258/ijddt.16.19s.7}
}
Kostenlos starten →